Alpha Cognition, Inc. (ACOG)
9.12
+0.29
(+3.28%)
USD |
NASDAQ |
Sep 21, 16:00
9.12
0.00 (0.00%)
After-Hours: 20:00
Alpha Cognition Enterprise Value : 150.82M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 150.82M |
| September 17, 2026 | 151.26M |
| September 16, 2026 | 141.46M |
| September 15, 2026 | 150.17M |
| September 14, 2026 | 148.21M |
| September 11, 2026 | 152.35M |
| September 10, 2026 | 152.35M |
| September 09, 2026 | 157.35M |
| September 08, 2026 | 165.85M |
| September 04, 2026 | 165.85M |
| September 03, 2026 | 159.10M |
| September 02, 2026 | 161.38M |
| September 01, 2026 | 158.23M |
| August 31, 2026 | 160.40M |
| August 28, 2026 | 158.01M |
| August 27, 2026 | 170.53M |
| August 26, 2026 | 163.45M |
| August 25, 2026 | 170.85M |
| August 24, 2026 | 170.85M |
| August 21, 2026 | 170.85M |
| August 20, 2026 | 165.41M |
| August 19, 2026 | 152.13M |
| August 18, 2026 | 145.27M |
| August 17, 2026 | 151.04M |
| August 14, 2026 | 151.04M |
| Date | Value |
|---|---|
| August 13, 2026 | 146.47M |
| August 12, 2026 | 153.44M |
| August 11, 2026 | 152.02M |
| August 10, 2026 | 152.13M |
| August 07, 2026 | 157.35M |
| August 06, 2026 | 147.34M |
| August 05, 2026 | 144.07M |
| August 04, 2026 | 153.22M |
| August 03, 2026 | 142.11M |
| July 31, 2026 | 138.85M |
| July 30, 2026 | 148.65M |
| July 29, 2026 | 150.17M |
| July 28, 2026 | 141.68M |
| July 27, 2026 | 145.38M |
| July 24, 2026 | 130.57M |
| July 23, 2026 | 137.76M |
| July 22, 2026 | 130.57M |
| July 21, 2026 | 130.36M |
| July 20, 2026 | 140.15M |
| July 17, 2026 | 143.64M |
| July 16, 2026 | 140.37M |
| July 15, 2026 | 139.28M |
| July 14, 2026 | 133.84M |
| July 13, 2026 | 141.02M |
| July 10, 2026 | 141.68M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agios Pharmaceuticals, Inc. | 1.385B |
| ACADIA Pharmaceuticals, Inc. | 3.815B |
| Alnylam Pharmaceuticals, Inc. | 31.72B |
| Anika Therapeutics, Inc. | 265.34M |
| Savara, Inc. | 960.37M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.790M |
| Revenue (Quarterly) | 6.093M |
| Total Expenses (Quarterly) | 14.88M |
| EPS Diluted (Quarterly) | -0.4037 |
| Gross Profit Margin (Quarterly) | 93.10% |
| Profit Margin (Quarterly) | -144.3% |
| Earnings Yield | -12.30% |
| Normalized Earnings Yield | -14.08 |